AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The shift toward telemedicine in hormone replacement therapy has seen a significant increase, particularly during the COVID-19 pandemic. Many individuals with normal testosterone levels were assessed by telemedicine clinics, often resulting in excessive and inappropriate prescriptions for testosterone replacement therapy (TRT). A notable study, referred to as the secret shopper study, highlighted that patients seeking testosterone were sometimes prescribed therapies without thorough evaluations of their cardiovascular health, reproductive intentions, or fertility preservation options. This trend raises concerns about the adequacy of patient assessments conducted by telemedicine providers, emphasizing the need for standardized guidelines to ensure safe prescribing practices.